Hemodialysis Global Market Report 2024

The hemodialysis market has grown strongly in recent years. It will grow from $89.87 billion in 2023 to $94.45 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The expansion observed in the historical period can be attributed to factors such as the rising incidence of chronic kidney disease (CKD), increasing awareness of renal health, government initiatives for renal care, the global expansion of dialysis centers, and lifestyle-related factors.

The hemodialysis market is expected to see strong growth in the next few years. It will grow to $117.37 billion in 2028 at a compound annual growth rate (CAGR) of 5.6%. The anticipated growth in the forecast period can be attributed to factors such as increasing healthcare expenditure, the integration of telehealth in renal care, regulatory support for home hemodialysis, a focus on personalized medicine in nephrology, and an emphasis on global health crisis preparedness. Key trends expected in the forecast period encompass the adoption of minimally invasive procedures, technological advancements, the development of patient-friendly devices, integration with imaging and diagnostics, and the implementation of customized treatment approaches in the field of hemodialysis.

The hemodialysis market is poised for growth due to the increasing prevalence of diabetes and kidney failure. Diabetes and kidney failure, interconnected medical conditions affecting blood glucose levels and the blood-filtering function, respectively, contribute to the rising demand for hemodialysis treatment. With the kidneys losing normal functionality, hemodialysis helps cleanse the blood of waste and excess fluid. Early detection and treatment of kidney disease further fuel the demand for hemodialysis. In September 2021, the United States Renal Data System (USRDS) reported nearly 786,000 people in the United States suffering from end-stage renal disease (ESRD), with 71% undergoing dialysis and 29% receiving kidney transplants. Thus, the increasing prevalence of diabetes and kidney failure is a driving force for the hemodialysis market.

The growth of the hemodialysis market is also influenced by the increasing incidence of lifestyle-related diseases, particularly obesity. Lifestyle-related diseases significantly impact an individual's health, playing a pivotal role in the development of chronic kidney disease (CKD), necessitating hemodialysis. The World Health Organization reported in March 2022 that over 1 billion people globally, including 650 million adults, 340 million teenagers, and 39 million children, suffer from obesity, a number continually rising. With lifestyle-related diseases contributing to CKD, the demand for hemodialysis is expected to grow significantly.

The technological advancements are a notable trend, with major companies concentrating on innovative technologies to maintain their market positions. In August 2022, Fresenius Medical Care AG & Co. KGaA introduced Speedswap, an innovative option for the NxStage System One with NxView. This technology allows changing a flow-compromised dialysis filter without replacing the entire cartridge, reducing therapy downtime, nursing workloads, and treatment costs in acute care settings. Technological innovation enhances patient care and operational efficiency in the hemodialysis sector.

A strategic partnership approach is adopted by major companies operating in the hemodialysis market to enhance patient outcomes and treatment experiences. In May 2022, Medtronic Plc announced a partnership with DaVita Inc. to establish a novel, independent medical device business called NewCo, focusing on kidney care. By combining Medtronic's healthcare technology expertise with DaVita's extensive experience as a comprehensive kidney care provider, NewCo aims to provide patients with greater access to innovative kidney care products and solutions, including home-based devices. This strategic partnership facilitates the creation of a wide range of kidney care offerings and advancements in dialysis treatments. The partnership structure includes equal equity holdings by Medtronic and DaVita in NewCo, which will be managed by a dedicated management team.

In April 2022, Dialyze Direct acquired Compass Home Dialysis, positioning Dialyze Direct to access new markets and expand its patient base in the end-stage renal disease (ESRD) dialysis sector. This strategic acquisition aims to increase revenue and profitability for Dialyze Direct. Compass Home Dialysis, a specialist in home hemodialysis, aligns with Dialyze Direct's objectives in the evolving landscape of kidney care.

Major companies operating in the hemodialysis market report are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., DaVita Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co. Ltd., Nipro Corporation, NxStage Medical Inc., Cantel Medical Corp., Diaverum, Becton Dickinson And Company, Toray Medical Co. Ltd., Outset Medical Inc., Quanta Dialysis Technologies, Allmed Medical Care Corporation, AngioDynamics LLC, Rockwell Medical Inc., Medivators Inc., Medtronic Plc, Gambro AB, Hemoclean Co. Ltd., JMS Co. Ltd., Kawasumi Laboratories Inc., Medcomp, Medline Industries Inc., Merit Medical Systems Inc., Poly Medicure Ltd., Renax Biomedical Tech. Co. Ltd., Teleflex Inc., Terumo Corporation, Thermo Fisher Scientific Inc., W. L. Gore & Associates Inc., Argon Medical Devices Inc., Boston Scientific Corporation, Cook Medical Inc.

North America was the largest region in the hemodialysis market in 2023. Asia-Pacific is expected to be the fastest growing region in the global hemodialysis market report during the forecast period. The regions covered in the hemodialysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hemodialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of hemodialysis include conventional hemodialysis, short daily hemodialysis or daily hemodialysis, and nocturnal hemodialysis. Conventional hemodialysis is typically conducted three times a week, with each session lasting several hours. Various components utilized in hemodialysis include the dialyzer, dialysis solution, tubes, catheter, and other related materials. These components find application across various end-users, including hospitals, specialty clinics, home-care settings, and others.

The hemodialysis market research report provides hemodialysis market statistics, including hemodialysis industry global market size, regional shares, competitors with a hemodialysis market share, detailed hemodialysis market segments, market trends and opportunities, and any further data you may need to thrive in the hemodialysis industry. This hemodialysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemodialysis market includes revenues earned by entities by in-center hemodialysis and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.